Cme (CME) Liabilities and Shareholders Equity (2009 - 2026)

Cme (CME) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $194.7 billion the latest figure, recorded in Q2 2026.

• Quarterly Liabilities and Shareholders Equity rose 8.21% year-over-year to $194.7 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $782.2 billion (up 27.61% YoY) and the FY2025 annual result came in at $198.4 billion, up 44.36% from the prior year.
• Liabilities and Shareholders Equity slipped to $194.7 billion in Q2 2026 per CME's latest filing, from $202.0 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for CME reached as high as $205.9 billion in Q1 2022 and fell as low as $123.4 billion in Q2 2024.
• A 5-year average of $164.4 billion and a median of $170.1 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity decreased 29.61% — and 2025, when it soared 45.82%.
• Year by year, Liabilities and Shareholders Equity stood at $174.2 billion in 2022, then retreated by 25.53% to $129.7 billion in 2023, then gained by 5.97% to $137.4 billion in 2024, then jumped by 44.36% to $198.4 billion in 2025, then fell by 1.89% to $194.7 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $194.7 billion, $202.0 billion, and $198.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.